Factor V – Published Papers using Affinity Biologicals Products

2011

Functional characterization of a novel missense mutation identified in a Turkish patient affected by severe coagulation factor V deficiency

EM PARABOSCHI, SM KAYIRAN, N ÖZBEK… – Haemophilia
The functional assay was based on the prothrombin time, whereas the antigen levels were measured using an enzyme immunoassay (EIA) based on a sheep antihuman FV polyclonal antibody (Affinity Biologicals, Ancaster, ON, Canada).

M Marchetti, L Russo, D Balducci… – Thrombosis Research, 2011 – Elsevier
To exclude the possibility that breast cancer cells might contribute to CP activity by endogenous FV, the CP chromogenic assay was also performed in the presence of an anti-FV polyclonal antibody (60 μg/mL fc; SAFV-IG; Affinity Biologicals Inc, Ancaster, ON Canada) [17].

2010

TJCJH Griffin… – 2010 – content.karger.com
M662C/D1828C-FVIII was characterized previously [15, 16] . FV-deficient plasma was from Affinity Biologicals (Ancaster, Ont., Canada).

C Duckers, P Simioni, L Spiezia… – …, 2010 – bloodjournal.hematologylibrary.org
In some thrombin generation experiments, an anti-FV polyclonal antibody (SAFV-IG; Affinity Biologicals Inc)

2009

J Song, I Guella, KY Kwon, H Cho… – Blood coagulation & …, 2009 – journals.lww.com
Blood Coagulation & Fibrinolysis: March 2009 – Volume 20 Factor V antigen plasma levels (FV: Ag) were measured by an enzyme-linked immunosorbent assay (ELISA) sandwich method using antihuman factor V polyclonal antibodies (Affinity Biologicals, Hamilton, Ontario